Home Mission News & Events Board of Directors BOT/MRC Lead-Cmte International


Jiliang Zhou (周继亮), MD/PhD

 

Professor
Department of Pharmacology & Toxicology
Medical College of Georgia
Augusta University
CB-3628 (Office); CB-3606 (Lab)
1459 Laney Walker Blvd
Augusta, GA 30912
Phone: 706-721-7582 (Office); 706-721-7583 (Lab)
Fax: 706-721-2347
Email: jizhou@augusta.edu

Website: https://www.augusta.edu/mcg/phmtox/jiliang_zhou_phd.php

 

 

Biography

 

Dr. Jiliang Zhou is a professor at the Department of Pharmacology & Toxicology Medical College of Georgia at Augusta University. He obtained his medical degree at the Jiangxi Medical College, China in 1996. After receiving his PhD degree at the Zhejiang University, China in 2002 he performed his postdoctoral training at the Indiana University School of Medicine in Indianapolis, USA. In 2008, Dr. Zhou started his independent research program at the Albany Medical College, NY as a tenure-track assistant professor. In 2012 he moved to Medical College of Georgia, GA as an associate professor and became a full professor in 2018.

 

Dr. Zhou studies smooth muscle biology. The long-term goal of his research program is to unravel the mechanisms regulating the phenotype of vascular smooth muscle cells, an essential cell type in the blood vessels that carry blood throughout the body. The Zhou laboratory seeks to define the epigenetic and transcriptional mechanisms controlling smooth muscle cell behavior that contributes to cardiovascular development, homeostasis, and disease. Current focus of the Zhou lab is on two major areas: Hippo-YAP-TEAD signaling and long non-coding RNAs (lncRNAs). His research has been continuously funded by the NIH and the AHA. Dr. Zhou has a consistent track record of research productivity and innovation in smooth muscle biology. Dr. Zhou is also a dedicated mentor and highly motivated to train the next generation of cardiovascular scientists.

 

 

 

Resource Center | News & Events
Copyright © 2014. All rights reserved. Site designed & maintained by AC Communications, Inc.